Ruscogenin alleviates cognitive dysfunction by inhibiting the activation of isoflurane-induced NLRP3 inflammasome in aged mice

Main Article Content

Xiaohu Liang
Xiaoqun Luo
Danping Li
Lingqiong Kong

Keywords

ruscogenin, cognitive dysfunction, isoflurane, NLRP3 inflammasome, postoperative cognitive dysfunction

Abstract

Ruscogenin exerts an anti-inflammatory effect in the pathogenesis of various human diseases, including pulmonary hypertension, acute lung injury, acute pancreatitis and cerebral ischemia. Its role in isoflurane-induced rats with postoperative cognitive dysfunction (POCD) was investigated in this study. Aged rats were exposed to isoflurane for establishing a model of POCD, and administered with ruscogenin by gavage. Cognitive dysfunction was evaluated by the Morris water maze test. Hematoxylin and Eosin (H&E) staining was designed to assess neuronal damage. Markers of brain damage and neuroinflammation were detected by enzyme-linked-immunosorbent serologic assay. Isoflurane exposure caused impaired cognitive function by increasing escape latency, decreasing the time taken for crossing target and time in target quadrant. However, administration of ruscogenin reversed these cognitive dysfunctions. Abnormal morphological phenomena on neurons and enhanced levels of serum calcium-binding protein β (S-100β) and neuron-specific enolase (NSE) were identified in mice post-isoflurane exposure. Administration of ruscogenin ameliorated the neuronal morphological damages and reduced the levels of S-100β and NSE in the hippocampi of isoflurane-induced aged mice. Ruscogenin also attenuated isoflurane-induced enhancements in the levels of Interleukin (IL)-1β, IL-6 and tumor necrosis factor-alpha in the hippocampi of mice. Isoflurane-induced enhancements in the mRNA expression levels of NLR family pyrin domain containing 3 (NLRP3), ASC, IL-1β and IL-18 proteins were also restored by administration of ruscogenin. Ruscogenin exerted neuroprotective effects against isoflurane-induced cognitive dysfunction and neuroinflammation through blocking of NLRP3 pathway.

Abstract 772 | PDF Downloads 644 HTML Downloads 275 XML Downloads 75

References

Alwardt, C.M., Redford, D. and Larson, D.F., 2005. General anesthesia in cardiac surgery: a review of drugs and practices. Journal of Extra-Corporeal Technology 37: 227–235. PMid: 16117465

Belcher, A., Leung, S., Cohen, B., Yang, D., Mascha, E., Turan, A., et al. 2017. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005–2013: a single center study. Journal of Clinical Anesthesia 43: 33–38. 10.1016/j.jclinane.2017.09.005

Belrose, J.C. and Noppens, R.R., 2019. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiology 19: 241. 10.1186/s12871-019-0903-7

Bi, L., Zhu, R., Kong, H., Wu, S.-l., Li, N., Zuo, X., et al. 2013. Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats. International Immunopharmacology 16(1): 7–16. 10.1016/j.intimp.2013.03.010

Cao, G., Jiang, N., Hu, Y., Zhang, Y., Wang, G., Yin, M., et al. 2016. Ruscogenin attenuates cerebral ischemia-induced blood–brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. International Journal of Molecular Sciences 17: 1418. 10.3390/ijms17091418

Cao, Y., Li, Z., Ma, L., Ni, C., Li, L., Yang, N., et al. 2018. Isoflurane-induced postoperative cognitive dysfunction is mediated by hypoxia-inducible factor-1α-dependent neuroinflammation in aged rats. Molecular Medicine Reports 17: 7730–7736. 10.3892/mmr.2018.8850

Chen, M.-H., Chen, X.-J., Wang, M., Lin, L.-G. and Wang, Y.-T., 2016. Ophiopogon japonicus—a phytochemical, ethnomedicinal and pharmacological review. Journal of Ethnopharmacology 2(181): 193–213. 10.1016/j.jep.2016.01.037

Chu, J.M.T., Xiong, W., Linghu, K.G., Liu, Y., Zhang, Y., Zhao, G.D., et al. 2018. Siegesbeckia Orientalis L. extract attenuates postoperative cognitive dysfunction, systemic inflammation, and neuroinflammation. Experimental Neurobiology 27: 564–573. 10.5607/en.2018.27.6.564

Cui, R.-S., Wang, K. and Wang, Z.-L., 2018. Sevoflurane anesthesia alters cognitive function by activating inflammation and cell death in rats. Experimental and Therapeutic Medicine 15(5): 4127–4130. 10.3892/etm.2018.5976

Ercan, G., Tartar, R.l., Solmaz, A., Gulcicek, O.B., Karagulle, O., Meric, S., et al. 2019. Examination of protective and therapeutic effects of ruscogenin on cerulein-induced experimental acute pancreatitis in rats. Annals of Surgical Treatment and Research 97: 271–281. 10.4174/astr.2019.97.6.271

Fan, Y., Du, L., Fu, Q., Zhou, Z., Zhang, J., Li, G. and Wu, J., 2018. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates isoflurane-induced pyroptosis and cognitive impairment in aged mice. Frontiers in Cellular Neuroscience 19(12): 426. 10.3389/fncel.2018.00426

Geng, Y.-j., Wu, Q.-h. and Zhang, R.-q., 2017. Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients: a randomized controlled trial. Journal of CLINICAL ANESthesia 38: 165–171. 10.1016/j.jclinane.2017.02.007

Guan, T., Liu, Q., Qian, Y., Yang, H., Kong, J., Kou, J. and Yu, B., 2013. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke. European Journal of Pharmacology 714: 303–311. 10.1016/j.ejphar.2013.07.036

Ho, Y.-S., Zhao, F.-Y., Yeung, W.-F., Wong, G.T.-C., Zhang, H.-Q. and Chang, R.C.-C., 2020. Application of acupuncture to attenuate immune responses and oxidative stress in postoperative cognitive dysfunction: what do we know so far? Oxidative Medicine and Cellular Longevity 2020: 9641904. 10.1155/2020/9641904

Hovens, I., Leeuwen, B., Mariani, M., Kraneveld, A. and Schoemaker, R., 2016. Postoperative cognitive dysfunction and neuroinflammation; cardiac surgery and abdominal surgery are not the same. Brain, Behavior, and Immunity 54: 178–193. 10.1016/j.bbi.2016.02.003

Huang, J.-M., Lv, Z.-T., Zhang, B., Jiang, W.-X. and Nie, M.-B., 2020. Intravenous parecoxib for early postoperative cognitive dysfunction in elderly patients: evidence from a meta-analysis. Expert Review of Clinical Pharmacology 13: 451–460. 10.1080/17512433.2020.1732815

Huang, Y., Xu, W. and Zhou, R., 2021. NLRP3 inflammasome activation and cell death. Cellular & Molecular Immunology 18(9):2114–2127. 10.1038/s41423-021-00740-6

Johnson, T., Monk, T., Rasmussen, L. S., Abildstrom, H., Houx, P., Korttila, K., Kuipers, H. M., et al., and ISPOCD2 Investigators, 2002. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology 96: 1351–1357. 10.1097/00000542-200206000-00014

Lin, D. and Zuo, Z., 2011. Isoflurane induces hippocampal cell injury and cognitive impairments in adult rats. Neuropharmacology 61: 1354–1359. 10.1016/j.neuropharm.2011.08.011

Lu, H.-J., Tzeng, T.-F., Liou, S.-S., Chang, C.J., Yang, C., Wu, M.-C. and Liu, I.M., 2014a. Ruscogenin ameliorates experimental nonalcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway. BioMed Research International 2014: 652680. 10.1155/2014/652680

Lu, H.-J., Tzeng, T.-F., Liou, S.-S., Da Lin, S., Wu, M.-C. and Liu, I.M., 2014b. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and antifibrotic effects in streptozotocin-induced diabetic rat. BMC Complementary and Alternative Medicine 14: 110–110. 10.1186/1472-6882-14-110

Safavynia, S.A. and Goldstein, P.A., 2019. The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment. Frontiers in Psychiatry 9: 752–752. 10.3389/fpsyt.2018.00752

Shao, A., Fei, J., Feng, S. and Weng, J., 2020. Chikusetsu saponin IVa alleviated sevoflurane-induced neuroinflammation and cognitive impairment by blocking NLRP3/caspase-1 pathway. Pharmacological Reports 72: 833–845. 10.1007/s43440-020-00078-2

Wang, C.-M., Chen, W.-C., Zhang, Y., Lin, S. and He, H.-F., 2021a. Update on the mechanism and treatment of sevoflurane-induced postoperative cognitive dysfunction. Frontiers in Aging Neuroscience 13: 702231. 10.3389/fnagi.2021.702231

Wang, Z., Meng, S., Cao, L., Chen, Y., Zuo, Z. and Peng, S., 2018. Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment. Journal of Neuroinflammation 15: 109. 10.1186/s12974-018-1137-1

Wang, Y.-w., Wu, Y.-h., Zhang, J.-z., Tang, J.-h., Fan, R.-p., Li, F., Yu, B.-y., Kou, J.-p. and Zhang, Y.-y., 2021b. Ruscogenin attenuates particulate matter-induced acute lung injury in mice via protecting pulmonary endothelial barrier and inhibiting TLR4 signaling pathway. Acta Pharmacologica Sinica 42: 726–734. 10.1038/s41401-020-00502-6

Wei, P., Yang, F., Zheng, Q., Tang, W. and Li, J., 2019. The potential role of the NLRP3 inflammasome activation as a link between mitochondria ROS generation and neuroinflammation in postoperative cognitive dysfunction. Frontiers in Cellular Neuroscience 21(13): 73. 10.3389/fncel.2019.00073

Wu, J., Li, H., Sun, X., Zhang, H., Hao, S., Ji, M., Yang, J. and Li, K., 2015. A mitochondrion-targeted antioxidant ameliorates isoflurane-induced cognitive deficits in aging mice. PloS One 10: e0138256. 10.1371/journal.pone.0138256

Zhang, Y., Hu, Y., Li, M., Wang, J., Guo, G., Li, F., Yu, B. and Kou, J., 2020. The traditional Chinese medicine compound GRS alleviates blood–brain barrier dysfunction. Drug Design, Development and Therapy 14: 933–947. 10.2147/DDDT.S229302

Zhao, S., Chen, F., Wang, D., Han, W., Zhang, Y. and Yin, Q., 2021. NLRP3 inflammasomes are involved in the progression of postoperative cognitive dysfunction: from mechanism to treatment. Neurosurgical Review 44: 1815–1831. 10.1007/s10143-020-01387-z